New tool aims to boost colon cancer screening in primary care
NCT ID NCT06625983
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed trial tested whether a decision support tool given before primary care visits helps more people get screened for colorectal cancer. Over 9,000 average-risk adults aged 45-75 who were overdue for screening took part. The tool was included in a pre-visit questionnaire to help patients make informed choices about screening methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CRC decision support tool
What this could lead to
If effective, this tool could help more people complete colorectal cancer screening, potentially catching cancer earlier and saving lives.
What could go wrong
The tool may not significantly increase screening rates, or its effect may vary across different patient groups. The trial is completed but results are not yet widely available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHARED DECISION-MAKING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mass General Brigham
Boston, Massachusetts, 02114, United States